London & Capital Asset Management’s GSK GSK Stock Holding History

London & Capital Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-27,052	Closed	-$1.05M	–	102
2025 Q1	$1.05M	Sell	27,052 -14,738	-35%	-$540K	0.09%	74
2024 Q4	$1.41M	Buy	41,790 +167	+0.4%	+$6.01K	0.12%	66
2024 Q3	$1.7M	Buy	41,623 +568	+1%	+$23.2K	0.13%	60
2024 Q2	$1.58M	Buy	41,055 +3,989	+11%	+$168K	0.13%	58
2024 Q1	$1.59M	Buy	37,066 +4,046	+12%	+$167K	0.12%	57
2023 Q4	$1.22M	Buy	33,020 +3,883	+13%	+$139K	0.1%	59
2023 Q3	$1.06M	Buy	29,137 +3,588	+14%	+$127K	0.1%	57
2023 Q2	$911K	Buy	+25,549	New	+$916K	0.09%	56

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

London & Capital Asset Management's GSK Position: Q2 2025 in Review

London & Capital Asset Management sold out of GSK (GSK) in Q2 2025, closing a stake of 27,052 shares — an estimated $1.05M sold.

London & Capital Asset Management first reported a position in GSK in Q2 2023 and held it in 8 quarters. The position peaked at $1.7M in Q3 2024. 890 funds tracked by Wall St. Rank hold GSK as of Q2 2025.

London & Capital Asset Management reported no remaining GSK position as of Q2 2025 after selling out during the quarter.
London & Capital Asset Management sold 27,052 GSK shares in Q2 2025, an estimated $1.05M.
London & Capital Asset Management first reported a position in GSK in Q2 2023 and held it in 8 quarters.
London & Capital Asset Management's GSK position peaked at $1.7M in Q3 2024.
890 funds tracked by Wall St. Rank held GSK as of Q2 2025.

Based on London & Capital Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.